drugset / Trial / NCT01461941
A Phase 2 Study of E6005 in Patients With Atopic Dermatitis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety profiles of E6005 ointment in patients with atopic dermatitis compared to vehicle. The pharmacokinetic profile after topical application of E6005 is also assessed.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-11
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LOTAMILAST | Small molecule | 0.2 % | Topical |